Advertisement

Picture EBD Group BIO-Europe 2021 Digital BEU2021 650x80
Organisation › Details

New Enterprise Associates (NEA)

New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With more than $20 billion in cumulative committed capital since the firm’s first fund closed in 1978, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 225 portfolio company IPOs and more than 375 acquisitions. *

 

Product Industry venture capital
Person Person Mott, David M. (New Enterprise Associates 200809 General Partner before MedImmune 200604–200806 CEO)
     
Region Region Menlo Park, CA
  Country United States (USA)
  Street 2855 Sand Hill Road
  City 94025 Menlo Park, CA
  Tel +1-650-854-9499
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency USD
  Annual sales 20,000,000,000 (capital, committed, cumulative 2019-03-28)
     
    * Document for �About Section�: Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel.
     
   
Record changed: 2021-06-11

Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for New Enterprise Associates (NEA)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2021 NYC A October 650x80px




» top